Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-25-230215

Options or other derivatives

  • Director acquired 1,642 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferrante Karen Jean · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,642 1,642 D
Loading xslF345X05/ownership.xml…